HONDA: Operations-based core competence The resource-based view argues that companies posses some unique resources (assets and capabilities) and competitive advantage is acquired by accumulating those strategic assets. Resources are any tangible (e.g. equipment‚ raw material) or intangible (e.g. firm image‚ processes‚ routines) things that a company owns and can use to carry out its crucial processes. Capabilities‚ are dynamic of a “doing” nature. Capabilities are “the ability of make use of resources
Premium Strategic management Management Capability approach
FEBRUARY 2002 Core Competence for Sustainable Competitive Advantage: A Structured Methodology for Identifying Core Competence Khalid Hafeez‚ YanBing Zhang‚ and Naila Malak Abstract—Core competencies are the crown jewels of a company and‚ therefore‚ should be carefully nurtured and developed. Companies can determine their future business directions based on the strengths of competencies. However‚ because generalized terms such as resource‚ asset‚ capability‚ and competence are not clearly explained
Premium Strategic management Management
an Indian public-listed company BIOCON Final Project Report Contents Background 3 Subsidiary Companies 4 Products and Services 4 The Auditors report 5 The Director’s Report 6 Accounting Policies 7 Balance sheet 14 Cash flow analysis 18 ANNEXURES 21 Ratio Analysis 23 New Terminologies 29 References 30 Background Established in 1978‚ Biocon is India ’s premier biotechnology company. Headquartered in Bangalore Biocon has evolved from an enzyme company
Premium Balance sheet Asset Income statement
STRATEGIC SWOT ANALYSIS: Strength: The strengths of Biocon are * Financial Leverage – Biocon has maintained a constant Debt/ Equity ratio between 0.11-0.12[1] in the last 5 years‚ which gives it a financial leverage‚ thus letting the share holders enjoy the earnings and also makes the organization financially strong. * Skills in Enzymes – Biocon with its recombinant DNA technology has managed to achieve a different share in the industry‚ its products like Insugen from recombinant human
Premium Biotechnology DNA Chemotherapy
Biocon Limited 1. Assuming Biocon receives approval for BioMAb‚ should it launch the drug immediately or conduct phase 3 trials before launch? Elaborate the various elements of your action plan. Even if the Drug Controller General of India (DCGI) grants permission for BIOMAb in fall 2006‚ Biocon should still conduct phase 3 trials before launching. Both Biocon and Clinigene are new to the industry and strong reputations have yet to be developed. Therefore‚ Biocon must means make sure BIOMAb
Premium Oncology Cancer Chemotherapy
Making Use of Resources‚ Capabilities and Core Competences. Resources‚ capabilities and core competences Resources‚ capabilities and core competencies are the foundation of competitive advantage. Resources are bundled to create organizational capabilities. In turn‚ capabilities are the source of a firm’s core competencies‚ which are the basis of competitive advantages. Here‚ we define and provide examples of these building blocks of competitive advantage. 1. Resources Broad in scope‚ resources
Premium Resource Management Strategic management
Biocon: Launching a New Cancer Drug in India Section E Group 5 Ankita Khandelwal (255) Bojja Raghavendar Reddy (265) Hitesh Chopra (275) Nikhil Singh Rawat (285) Raghavan K. V. (295) Vaibhav Saxena (305) Situation Analysis: • Biocon is an Indian Drug company that has evolved over the years: ▪ It was an enzyme manufacturer for food industry and developed expertise
Premium Oncology Cancer Chemotherapy
www.hbr.org The Core Competence of the Corporation by C.K. Prahalad and Gary Hamel Included with this full-text Harvard Business Review article: 1 Article Summary The Idea in Brief—the core idea The Idea in Practice—putting the idea to work 2 The Core Competence of the Corporation 15 Further Reading A list of related materials‚ with annotations to guide further exploration of the article’s ideas and applications Reprint 90311 The Core Competence of the Corporation The Idea in Brief
Premium Strategic management Management Harvard Business School
Corporate Social Responsibility While Biocon was involved in community programs from inception‚ it started a corporate social responsibility wing—the Biocon Foundation—in 2004 through which it works in the areas of health‚ education and infrastructure‚ especially in rural areas. Health Through the Arogya Raksha Yogana (ARY) clinics‚ Biocon helps meet the primary‚ tertiary and secondary healthcare needs of various communities. Its 7 ARY clinics—located where healthcare facilities are poor—offer
Premium Hygiene Karnataka Sanitation
Biocon Case Assignment Questions 1. Assuming Biocon receives approval for BIOMAb‚ should it launch the drug immediately or conduct phase 3 trials before launch? Elaborate the various elements of your action plan. If Biocon receives approval for BIOMAb‚ the management team will need to carefully consider what the best course of action is moving forward. If the company elects to launch the drug immediately‚ they will be able to have the first mover advantage‚ reaching the market before their
Premium Pharmaceutical industry Oncology First-mover advantage